References
- Landis SH, Murray T, Bolden S, et al. Cancer statistics 1999. CA 1999;49(1):8–11
- Stein B, Lindenmayer JM. Proposed prostate cancer screening recommendations. Medicine and Health/Rhode Island 1997;80(10):343–5
- Chodak GW. The role of watchful waiting in the management of localized prostate cancer. J Urol 1994;152:1766–8
- Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA 1997;277(18): 1445–51
- Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the medical research council trial. Br J Urol 1997;79:235–46
- Gleave M, Goldenburg SL, Jones E, et al. Biochemical and pathological effects of eight months of neoadjuvant androgen withdrawal therapy: an update on 125 consecutive patients. (Abstr) J Urol 1997; 157(4): 390
- McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 1998;338(9):557–63
- US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. Urinary incontinence in adults: acute and chronic management. Clinical practice guideline, Number 2, 1996 update. Publication No. 96–0682, Rockville, MD.
- Haab F, Zimmern PE, Leach GE. Female stress urinary incontinence due to intrinsic sphincter deficiency: recognition and management. J Urol 1996;156:3–17
- Burgio KL, Locher JL, Goode PS, et al. Behavioral vs drug treatment for urge urinary incontinence in older women. JAMA 1998;280(23); 1995–2000